Hydrogen Therapy Reduces COVID-19 Symptoms and Inflammation
- Authors
- Peng Luo, Yuanfang Ding, Yuan He, Dafeng Chen, Qing He, Zufeng Huang, Shian Huang, Wei Lei
- Journal
- Medicine
- Year
- 2022
- DOI
- 10.1097/MD.0000000000027759
- Study Type
- Human
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- COVID-19
- Body System
- Respiratory
TL;DR
A study found that adding hydrogen-oxygen therapy to standard treatment might reduce inflammation in COVID-19 patients.
Key Finding
COVID-19 patients who received hydrogen-oxygen therapy showed significant reductions in inflammatory markers (neutrophil percentage and C-reactive protein) compared to those receiving standard treatment alone.
Summary
This small study looked at 12 COVID-19 patients who received hydrogen-oxygen gas therapy in addition to standard treatment, compared to 12 patients who received standard treatment alone. The patients receiving hydrogen-oxygen therapy showed decreases in certain inflammatory markers (neutrophil percentage and C-reactive protein), which are signs of inflammation in the body.
Practical Takeaway
This early evidence from a small human study suggests hydrogen-oxygen therapy may help reduce inflammation in COVID-19 patients, but the study is too limited (only 12 patients per group, no details on symptom improvement) to draw firm conclusions. Much larger and more rigorous studies would be needed before this could be considered an established treatment.
Abstract (excerpt)
Abstract A global public health crisis caused by the 2019 novel coronavirus disease (COVID-19) leads to considerable morbidity and mortality, which bring great challenge to respiratory medicine. Hydrogen-oxygen therapy contributes to treat severe respiratory diseases and improve lung functions, yet…